{"lastClose": 5.369999885559082, "len": 1116, "date": "2023-03-20", "alpha_1": -0.3483348702596949, "beta_1": 1.5709802923412655, "drawup_1": 1.5486725887776869, "natr_1": 15.675128481526507, "sup_1": -0.10055865425717915, "res_1": 0.5865922090312071, "bullPattern_1": [], "bearPattern_1": ["3OUTSIDE"], "rsi_1": 20.416654497380673, "adx_1": 43.0401374974305, "drawdown_1": -0.6892361300824961, "stratHoldSharpe_1": -0.43622168066642747, "stratHoldAlpha_1": 250.70629762017273, "stratHoldDrawdown_1": -0.6485358364805892, "alpha_3mo": -0.25245280290225247, "beta_3mo": 1.60939902045556, "drawup_3mo": 0.4608541290620036, "natr_3mo": 15.675128481526507, "sup_3mo": -0.01489753565460401, "res_3mo": 0.17690877977694197, "bullPattern_3mo": ["BELTHOLD", "LONGLINE"], "bearPattern_3mo": [], "rsi_3mo": 12.307683278821054, "adx_3mo": 12.192343809615428, "drawdown_3mo": -0.3459196272097569, "stratHoldSharpe_3mo": -0.7098057926344951, "stratHoldAlpha_3mo": 250.58627257288381, "stratHoldDrawdown_3mo": -0.3189418675292115, "Sector": "Health Care", "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "Country": "United States", "Market Cap": 774408527, "Name": "Allogene Therapeutics Inc.", "IPO Year": 2018.0, "alpha%_1": 0.16420797331218262, "beta%_1": 0.8894415818054686, "drawup%_1": 0.9976496438266821, "natr%_1": 0.9999953400511576, "drawdown%_1": 0.05552141428697421, "stratHoldSharpe%_1": 0.3334262827435778, "stratHoldAlpha%_1": 0.171565106755859, "stratHoldDrawdown%_1": 0.04312909907040499, "alpha%_3mo": 0.27877938980684713, "beta%_3mo": 0.8565012355623454, "drawup%_3mo": 0.9120562161644414, "natr%_3mo": 0.9999931112259607, "drawdown%_3mo": 0.07100355776335993, "stratHoldSharpe%_3mo": 0.30666667985147034, "stratHoldAlpha%_3mo": 0.2262999405166446, "stratHoldDrawdown%_3mo": 0.06857223659036236}